- ICH GCP
- US Clinical Trials Registry
- Researchers
- Canada
- Pancreatic Neoplasms
Medical specialists from Canada tagged as investigators in clinical trials studying Pancreatic Neoplasms
Total 59 results
-
Karen Mulder, MDSeen in:
- Alberta, Edmonton, Cross Cancer Institute
Trials:- NCT03678883 (Principal Investigator)
- NCT01586611 (Sub-Investigator)
Conditions:- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma;
- Metastatic Pancreas Cancer
-
Lillian Siu, MDSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
- Ontario, Toronto, Princess Margaret Hospital
- Ontario, Toronto, University Health Network / Princess Margaret Cancer Centre
Trials:- NCT03702309 (Principal Investigator)
- NCT05592626 (Principal Investigator)
- NCT02906943 (Principal Investigator)
- NCT05403177 (Principal Investigator)
- NCT05196087 (Principal Investigator)
- NCT04273061 (Principal Investigator)
Conditions:- Melanoma;
- Lymphoma;
- Kidney Cancer;
- Leukemia;
- Cancer;
- Breast Cancer;
- Head and Neck Cancer;
- Ovarian Cancer;
- Lynch Syndrome;
- Lung Cancer;
- Colon Cancer;
- Meningioma;
- BRCA1 Mutation;
- BRCA2 Mutation;
- Myeloma;
- Mutation;
- Uterine Cancer;
- Cowden Syndrome;
- Neoplasms;
- Urogenital Neoplasms;
- Neoplasms by Site;
- Carcinoma;
- Epstein-Barr Virus Infections;
- Advanced Solid Tumors;
- Vulvar Neoplasms;
- Vulvar Diseases;
- Abdominal Neoplasm;
- Lung Neoplasm;
- Papillomavirus Infection;
- Genital Neoplasm, Female;
- Colorectal Cancer;
- Gastrointestinal Cancer;
- Genitourinary Cancer;
- Unknown Primary Cancer;
- Gynecological Cancer;
- Rare Cancer;
- Pancreatobiliary Cancer;
- Solid Tumor;
- Prostate Cancer;
- Pancreas Cancer;
- Ovary Cancer;
- Gastrointestinal Neuroendocrine Tumor;
- Sarcoma;
- Gynecologic Cancer;
- Skin Cancer;
- Unknown Primary Tumors
-
Lucy GilbertSeen in:
- Quebec, Montreal, McGill University Department of Oncology / McGill University Health Centre
- Quebec, Montreal, McGill University Health Centre
- Quebec, Montréal, McGill University Health Centre
- Quebec, Montréal, McGill University Health Centre (MUHC)
Trials:- NCT05456685 (Principal Investigator)
- NCT05611931 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT06003231 (Principal Investigator)
Conditions:- Fallopian Tube Cancer;
- Primary Peritoneal Cancer;
- High Grade Ovarian Cancer;
- Endometrial Cancer;
- Neoplasms;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Ovarian Cancer;
- Rectal Cancer;
- Triple Negative Breast Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer;
- Carcinoma, Non-Small-Cell Lung;
- Ovarian Neoplasms;
- Endometrial Neoplasms;
- Carcinoma, Squamous Cell of Head and Neck
-
Maxime Chénard-Poirier, MDSeen in:
- Quebec, Quebec City, CHU de Québec
Trials:- NCT06349278 (Sub-Investigator)
Conditions: -
Melina Boutin, MDSeen in:
- Quebec, Greenfield Park, Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre
Trials:- NCT03678883 (Principal Investigator)
Conditions:- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma
-
Michael J. RaphaelSeen in:
- Ontario, Toronto, Odette Cancer Centre- Sunnybrook Health Sciences Centre
Trials:- NCT04340141 (Principal Investigator)
-
Neil ChuaSeen in:
- Alberta, Edmonton, University of Alberta / Cross Cancer Institute
Trials:- NCT03485209 (Principal Investigator)
-
Nicholas A. BosmaSeen in:
- British Columbia, Victoria, BCCA-Vancouver Island Cancer Centre
Trials:- NCT04340141 (Principal Investigator)
-
Pablo E. SerranoSeen in:
- Ontario, Hamilton, Juravinski Cancer Centre at Hamilton Health Sciences
Trials:- NCT04239573 (Principal Investigator)
- NCT04340141 (Principal Investigator)
-
Patricia TangSeen in:
- Alberta, Calgary, Tom Baker Cancer Centre
Trials:- NCT04068103 (Principal Investigator)
- NCT04340141 (Principal Investigator)
-
Paul J. KaranicolasSeen in:
- Ontario, Toronto, Odette Cancer Centre- Sunnybrook Health Sciences Centre
Trials:- NCT04239573 (Principal Investigator)
Conditions: -
Petr Kavan, MDSeen in:
- Quebec, Montréal, Jewish General Hospital
Trials:- NCT03678883 (Principal Investigator)
- NCT05477576 (Principal Investigator)
- NCT04698915 (Principal Investigator)
Conditions:- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma;
- Neuroendocrine Tumors;
- Carcinoid Tumor;
- Gastroenteropancreatic Neuroendocrine Tumor;
- Carcinoid;
- GEP-NET;
- Gastroenteropancreatic Neuroendocrine Tumor Disease;
- Pancreatic NET;
- Unresectable Pancreatic Cancer;
- Borderline Resectable Pancreatic Cancer;
- SBRT
-
Phillippe Bedard, MDSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
Trials:- NCT04429542 (Principal Investigator)
Conditions:- Head and Neck Neoplasms;
- Carcinoma, Squamous Cell;
- Colorectal Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Epithelial Ovarian Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Pancreas Cancer;
- Squamous Cell Carcinoma of the Lung;
- Cutaneous Squamous Cell Carcinoma;
- Squamous Cell Carcinoma of Anal Canal;
- EGFR Amplification
-
Prafull GhatageSeen in:
- Alberta, Calgary, Tom Baker Cancer Centre
Trials:- NCT02632448 (Principal Investigator)
-
Quincy ChuSeen in:
- Alberta, Edmonton, Cross Cancer Institute
- Alberta, Edmonton, GSK Investigational Site
Trials:- NCT04260802 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT03739710 (Principal Investigator)
- NCT06077877 (Principal Investigator)
Conditions:- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Ovarian Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
-
Ravi A. RamjeesinghSeen in:
- Nova Scotia, Halifax, QEII Health Sciences Centre/Nova Scotia Health Authority
Trials:- NCT04340141 (Principal Investigator)
-
Ravi Ramjeesingh, MDSeen in:
- Halifax, Nova Scotia, Atlantic Clinical Cancer Research Unit/QEII Health Sciences Centre
- Nova Scotia, Halifax, QE II Health Sciences Centre
Trials:- NCT03678883 (Principal Investigator)
- NCT04698915 (Principal Investigator)
Conditions:- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma;
- Unresectable Pancreatic Cancer;
- Borderline Resectable Pancreatic Cancer;
- SBRT
-
Rebecca Wong, MDSeen in:
- Toronto, University Health Network - Princess Margaret Cancer Centre
Trials:- NCT05477576 (Principal Investigator)
-
Samuel SaibilSeen in:
- Ontario, Toronto, University Health Network- Princess Margaret Cancer Centre
- Other, Toronto, University Health Network, Princess Margaret Hospital
Trials:- NCT05571839 (Principal Investigator)
- NCT06377111 (Principal Investigator)
-
Sarto Paquin, MDSeen in:
- Quebec, Montreal, Centre de Recherche du Centre Hospitalier de l'Universite de Montreal
Trials:- NCT04951804 (Sub-Investigator)
Conditions: -
Sean BennettSeen in:
- Ontario, Kingston, Kingston Health Sciences Centre
Trials:- NCT04239573 (Principal Investigator)
Conditions: -
Sharlene Gill, MDSeen in:
- British Columbia, Vancouver, BC Cancer - Vancouver
Trials:- NCT03450018 (Sub-Investigator)
- NCT02869802 (Sub-Investigator)
-
Sten Myrehaug, MDSeen in:
- Ontario, Toronto, Sunnybrook Health Sciences Centre
Trials:- NCT05477576 (Principal Investigator)
-
Steven GallingerSeen in:
- Ontario, Toronto, Uhn Mount Sinai Hospital
Trials:- NCT04970056 (Principal Investigator)
-
Timothy Nguyen, MDSeen in:
- Ontario, London, London Regional Cancer Center
Trials:- NCT04698915 (Principal Investigator)
-
Wilson H. MillerSeen in:
- Quebec, Montreal, Jewish General Hospital
Trials:- NCT05571839 (Principal Investigator)
- NCT04609566 (Principal Investigator)
-
Wilson MillerSeen in:
- Quebec, Montreal, Jewish General Hospital
- Quebec, Montreal, Jewish General Hospital - Clinical Research Unit
Trials:- NCT04260802 (Principal Investigator)
- NCT02632448 (Principal Investigator)
Conditions:- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Ovarian Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
-
Yvette DrewSeen in:
- British Columbia, Vancouver, BC Cancer Agency
Trials:- NCT02632448 (Principal Investigator)
Clinical Trials on Pancreatic Neoplasms
-
City of Hope Medical CenterRecruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Resectable | Pancreatic Carcinoma | Pancreatic Cancer Non-resectable | Pancreatic Cancer Stage III | Pancreatic Cancer Stage | Pancreatic Cancer Stage II | Pancreatic Cancer, Adult | Pancreatic... and other conditionsKorea, Republic of, United States, Japan
-
Memorial Sloan Kettering Cancer CenterRecruitingPancreatic Cancer | Pancreatic Cancer Metastatic | Pancreatic Cancer Stage IV | Metastatic Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Pancreatic Carcinoma | Metastatic Pancreatic Cancer | Pancreatic Cancer Non-resectable | Metastatic Pancreatic Ductal Adenocarcinoma | Pancreatic Carcinoma... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CelgeneWithdrawnPancreatic Ductal Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of UtahNovartis PharmaceuticalsRecruitingMetastatic Pancreatic Carcinoma | Unresectable Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedPancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer | Poorly Differentiated Malignant Neoplasm | Undifferentiated Pancreatic CarcinomaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Celgene CorporationCompletedPancreatic Adenocarcinoma | Resectable Pancreatic CarcinomaUnited States
-
Laser Tissue Welding, Inc.National Cancer Institute (NCI); CHI St. Luke's Health, TexasCompletedPancreatic Neoplasms | Pancreatic Adenocarcinoma | Pancreatic Cyst | Pancreatic Neuroendocrine Tumor | Pancreatic Polypeptide Tumor | Pancreatic Pseudocyst | Pancreatic Glucagonoma | Pancreas Injury | Pancreatic Cystadenoma | Pancreatic Tumor, Benign | Pancreas; Insulinoma | Pancreatic Teratoma | Pancreatic Vipoma and other conditionsUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingLocally Advanced Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Pancreatic NeoplasmChina
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer